Bio€quity Europe 2025
Biotech's Complex Moment: What's Next for Europe?
Biotech just became more complicated. The hottest trend is the competitive sourcing of assets from Asia to launch newcos in the West.
At the same time, geopolitics is creating pressures against globalization and the exchange of data and talent across borders.
In its 25th year, Bio€quity Europe asks what's next for European biotech. Can it rise to the complexity of the moment? Can it match the growing competition and walk the fine line of geopolitics?
Join BioCentury, EBD Group, and Regional Host Committee Chair Flanders Investment & Trade at this destination event for biopharma decision-makers to network, partner and debate critical issues facing the biotech industry.
flanders.bio members benefit from 15% discount on all registration types. Please contact us to obtain your VIP-code.